THE CONAFAY GROUP, LLC

Lobbying for ACADIA PHARMACEUTICALS INC. · Pharmaceutical Company

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $10,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Support for biomedical research.

Medicare/Medicaid

Medicare and Medicaid Reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.